Trial Review

Registering a new trial?

To achieve prospective registration, we recommend submitting your trial for registration at the same time as ethics submission.

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been endorsed by the ANZCTR. Before participating in a study, talk to your health care provider and refer to this information for consumers
Trial registered on ANZCTR


Registration number
ACTRN12620000626965
Ethics application status
Approved
Date submitted
21/04/2020
Date registered
29/05/2020
Date last updated
29/05/2020
Date data sharing statement initially provided
29/05/2020
Type of registration
Prospectively registered

Titles & IDs
Public title
Exploring Urethral Pressure Injuries in Adults with Long-Term Urinary Catheters
Scientific title
Exploring the Prevalence of Urethral Catheter Associated Mucosal Pressure Injuries in the Darling Downs Hospital and Health Service (DDHHS) & West Moreton Hospital and Health Service (WMHHS) Districts: A Cross-Sectional Study
Secondary ID [1] 301082 0
None
Universal Trial Number (UTN)
Trial acronym
Linked study record

Health condition
Health condition(s) or problem(s) studied:
Urethral Pressure Injuries 317152 0
Long Term Indwelling Urinary Catheters 317153 0
Condition category
Condition code
Renal and Urogenital 315302 315302 0 0
Other renal and urogenital disorders

Intervention/exposure
Study type
Observational
Patient registry
False
Target follow-up duration
Target follow-up type
Description of intervention(s) / exposure
Adults who have had an indwelling urinary catheter (IDC) in place for at least 4 weeks will be invited to complete a single survey. This survey will ask participants if they have been diagnosed with a pressure injury or ulcer while the IDC was in situ. The survey will also ask about common signs and symptoms of urethral pressure injury. It is anticipated that the survey will take 10-15 minutes to complete.

In addition, investigators will review the medical records of participants to:
1. Identify any documentation of urethral pressure injuries or ulcers in medical records
2. Record relevant demographic and medical data
Intervention code [1] 317392 0
Not applicable
Comparator / control treatment
No control group
Control group
Uncontrolled

Outcomes
Primary outcome [1] 323545 0
Prevalence of urethral pressure injuries in adults with long term IDCs in situ. Prevalence will be measured by:
i. Data obtained from surveys completed by participants
ii. Documentation of urethral pressure injuries or ulcers in medical records
Timepoint [1] 323545 0
Within 12 months of initial IDC insertion.
Secondary outcome [1] 382193 0
Age at time of IDC insertion. This will be collected from participant's medical records.
Timepoint [1] 382193 0
Age (at time of IDC insertion) will be collected from participant's medical records within 12 months of IDC insertion.
Secondary outcome [2] 382194 0
Sex (i.e. Male or Female). This will be collected from participant's medical records.
Timepoint [2] 382194 0
Sex (i.e. Male or Female) will be collected from participant's medical records within 12 months of IDC insertion.
Secondary outcome [3] 382195 0
Date of initial IDC insertion. This will be collected from participant's surveys and medical records.
Timepoint [3] 382195 0
Date of initial IDC insertion will be collected at survey completion within 12 months of IDC insertion.
Secondary outcome [4] 382196 0
Number of IDC changes. This will be collected from participant's surveys and medical records.
Timepoint [4] 382196 0
Number of IDC changes will be collected at survey completion within 12 months of IDC insertion.
Secondary outcome [5] 382197 0
Time (i.e. weeks) in between IDC changes. This will be collected from participant's surveys and medical records.
Timepoint [5] 382197 0
Time (i.e. weeks) in between IDC changes will be collected at survey completion within 12 months of IDC insertion.
Secondary outcome [6] 382198 0
Total duration of IDC insertion (i.e. months, weeks, and days). This will be collected from participant's surveys and medical records.
Timepoint [6] 382198 0
Total duration of IDC insertion (i.e. months, weeks, and days) will be collected at survey completion within 12 months of IDC insertion.
Secondary outcome [7] 382199 0
IDC material. This will be collected from participant's medical records.
Timepoint [7] 382199 0
IDC material will be collected from medical records within 12 months of IDC insertion.
Secondary outcome [8] 382200 0
IDC size. This will be collected from participant's medical records.
Timepoint [8] 382200 0
IDC size will be collected from medical records within 12 months of IDC insertion.
Secondary outcome [9] 382201 0
BMI at initial IDC insertion. This will be collected from participant's medical records.
Timepoint [9] 382201 0
BMI (i.e. at initial IDC insertion) will be collected from medical records within 12 months of IDC insertion.
Secondary outcome [10] 382202 0
Mobility status at initial IDC insertion (i.e. Independent, Supervision, Stand by assistance, Moderate assistance, or Maximal assistance). This will be collected from participant's medical records.
Timepoint [10] 382202 0
Mobility status (i.e. at initial IDC insertion) will be collected from medical records within 12 months of IDC insertion.
Secondary outcome [11] 382203 0
Smoking status at initial IDC insertion. This will be collected from participant's medical records.
Timepoint [11] 382203 0
Smoking status (i.e. at initial IDC insertion) will be collected from medical records within 12 months of IDC insertion.
Secondary outcome [12] 382204 0
Urological procedures (e.g. flexible cystoscopy, rigid cystoscopy, ureteric stent insertion, TURP, etc) that have been performed before AND/OR after initial IDC insertion. This will be collected from participant's medical records within 12 months of IDC insertion.
Timepoint [12] 382204 0
Urological procedures (i.e. that have been performed before AND/OR after initial IDC insertion) will be collected from medical records within 12 months of IDC insertion.
Secondary outcome [13] 382205 0
ICU admission during time when IDC was in-situ. This will be collected from participant's medical records within 12 months of IDC insertion.
Timepoint [13] 382205 0
ICU admission (i.e. during time when IDC was in-situ) will be collected from medical records within 12 months of IDC insertion.
Secondary outcome [14] 382206 0
Co-morbidities (i.e. Urological, Neurological, Cardiovascular, Respiratory, Metabolic, Immunological/Autoimmune, Cognitive, Oncological) during the time when the IDC was in-situ. This will be collected from participant's medical records within 12 months of IDC insertion.
Timepoint [14] 382206 0
Co-morbidities (i.e. during the time IDC was in-situ) will be collected from medical records within 12 months of IDC insertion.

Eligibility
Key inclusion criteria
In order to be eligible to participate in this project, candidates must fulfil all of the following criteria:
• >18 years of age
• Have capacity to consent
• Had an IDC in-situ for > 4 weeks between January 2019 and June 2020
• Provide written consent via signature of the Participant Consent Form
Minimum age
18 Years
Maximum age
No limit
Sex
Both males and females
Can healthy volunteers participate?
No
Key exclusion criteria
Key exclusion criteria:
• <18 years of age
• Lack capacity to consent
• Do not provide written consent via signature of the Participant Consent Form

Study design
Purpose
Natural history
Duration
Cross-sectional
Selection
Defined population
Timing
Retrospective
Statistical methods / analysis
Data will be analysed with assistance from a statistician. Descriptive statistics will be performed to illustrate trends and observations within the data.

Recruitment
Recruitment status
Not yet recruiting
Date of first participant enrolment
Anticipated
1/06/2020
Actual
Date of last participant enrolment
Anticipated
31/08/2020
Actual
Date of last data collection
Anticipated
31/12/2020
Actual
Sample size
Target
100
Accrual to date
Final
Recruitment in Australia
Recruitment state(s)
QLD
Recruitment hospital [1] 16513 0
Toowoomba Hospital - Toowoomba
Recruitment hospital [2] 16514 0
St Vincent's Hospital - Toowoomba
Recruitment hospital [3] 16515 0
Ipswich Hospital - Ipswich
Recruitment postcode(s) [1] 30070 0
4350 - Toowoomba
Recruitment postcode(s) [2] 30071 0
4305 - Ipswich

Funding & Sponsors
Funding source category [1] 305520 0
Self funded/Unfunded
Name [1] 305520 0
Dr Devang Desai
Country [1] 305520 0
Australia
Funding source category [2] 305820 0
Hospital
Name [2] 305820 0
Toowoomba Hospital
Country [2] 305820 0
Australia
Primary sponsor type
Individual
Name
Dr Devang Desai
Address
Department of Urology
Toowoomba Hospital
154 West Street
Toowoomba
QLD
4350
Country
Australia
Secondary sponsor category [1] 305926 0
None
Name [1] 305926 0
Address [1] 305926 0
Country [1] 305926 0

Ethics approval
Ethics application status
Approved
Ethics committee name [1] 305832 0
Darling Downs Hospital and Health Service Human Research Ethics Committee
Ethics committee address [1] 305832 0
Ethics committee country [1] 305832 0
Australia
Date submitted for ethics approval [1] 305832 0
03/03/2020
Approval date [1] 305832 0
17/04/2020
Ethics approval number [1] 305832 0
HREA/2020/QTDD/62452

Summary
Brief summary
Trial website
Trial related presentations / publications
Public notes

Contacts
Principal investigator
Name 101750 0
Dr Devang Desai
Address 101750 0
Department of Urology
Toowoomba Hospital
154 West Street
Toowoomba
QLD
4350
Country 101750 0
Australia
Phone 101750 0
+61 0408154889
Fax 101750 0
Email 101750 0
[email protected]
Contact person for public queries
Name 101751 0
Devang Desai
Address 101751 0
Department of Urology
Toowoomba Hospital
154 West Street
Toowoomba
QLD
4350
Country 101751 0
Australia
Phone 101751 0
+61 0408154889
Fax 101751 0
Email 101751 0
[email protected]
Contact person for scientific queries
Name 101752 0
Devang Desai
Address 101752 0
Department of Urology
Toowoomba Hospital
154 West Street
Toowoomba
QLD
4350
Country 101752 0
Australia
Phone 101752 0
+61 0408154889
Fax 101752 0
Email 101752 0
[email protected]

Data sharing statement
Will individual participant data (IPD) for this trial be available (including data dictionaries)?
No
No/undecided IPD sharing reason/comment


What supporting documents are/will be available?

No Supporting Document Provided



Results publications and other study-related documents

Documents added manually
No documents have been uploaded by study researchers.

Documents added automatically
SourceTitleYear of PublicationDOI
Dimensions AICatheter-associated meatal pressure injuries (CAMPI) in patients with long-term urethral catheters—a cross-sectional study of 200 patients2024https://doi.org/10.21037/tau-23-445
N.B. These documents automatically identified may not have been verified by the study sponsor.